T cells targeting NY-ESO-1 demonstrate efficacy against disseminated neuroblastoma

The cancer-testis antigen NY-ESO-1 is expressed by many solid tumors and has limited expression by mature somatic tissues, making it a highly attractive target for tumor immunotherapy. Targeting NY-ESO-1 using engineered T cells has demonstrated clinical efficacy in the treatment of some adult tumor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncoimmunology
Main Authors: Singh, Nathan, Kulikovskaya, Irina, Barrett, David M., Binder-Scholl, Gwendolyn, Jakobsen, Bent, Martinez, Daniel, Pawel, Bruce, June, Carl H., Kalos, Michael D., Grupp, Stephan A.
Formato: Artigo
Idioma:Inglês
Publicado em: Taylor & Francis 2015
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4760344/
https://ncbi.nlm.nih.gov/pubmed/26942053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2015.1040216
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados